{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:04:04Z","timestamp":1793293444367,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejca.2022.03.008","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T16:33:44Z","timestamp":1652373224000},"page":"236-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":309,"special_numbering":"C","title":["European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022"],"prefix":"10.1016","volume":"170","author":[{"given":"Claus","family":"Garbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Arenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Basset-Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bastholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dr\u00e9no","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kelleners-Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Lytvynenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreno-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Saiag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Stratigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.J.","family":"Van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lorigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.03.008_bib1","unstructured":"Howick JCI, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et\u00a0al. In: Group OLoEW, editor The Oxford levels of evidence 2: Oxford center for evifdence-based medicine https:\/\/wwwcebmnet\/indexaspx?o=5653 Access Date: 23 April 2019."},{"key":"10.1016\/j.ejca.2022.03.008_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.03.008_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejca.2009.10.032","article-title":"Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline","volume":"46","author":"Garbe","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/CMR.0b013e3282f05039","article-title":"Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma","volume":"17","author":"Garbe","year":"2007","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CMR.0b013e3282f702bf","article-title":"Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting","volume":"18","author":"Garbe","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib6","doi-asserted-by":"crossref","first-page":"w13320","DOI":"10.4414\/smw.2011.13320","article-title":"Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma","volume":"141","author":"Dummer","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ejca.2022.03.008_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/CMR.0b013e3282f0c893","article-title":"Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma","volume":"18","author":"Garbe","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.2010.09883.x","article-title":"Revised U.K. guidelines for the management of cutaneous melanoma 2010","volume":"163","author":"Marsden","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib9","first-page":"325","article-title":"Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report","volume":"17","author":"Saiag","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.ejca.2022.03.008_bib10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations to 2031","volume":"136","author":"Whiteman","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1034\/j.1600-0749.2003.00047.x","article-title":"Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data","volume":"16","author":"Bauer","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1523-1747.ep12374298","article-title":"Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society","volume":"102","author":"Garbe","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/1097-0142(19900715)66:2<387::AID-CNCR2820660232>3.0.CO;2-J","article-title":"Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma","volume":"66","author":"Grob","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(87)70230-8","article-title":"Number of melanocytic nevi as a major risk factor for malignant melanoma","volume":"17","author":"Holly","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1470-2045(06)71010-5","article-title":"Management of familial melanoma","volume":"8","author":"Bishop","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2007.01.010","article-title":"From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients","volume":"56","author":"de Snoo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib17","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.008_bib18","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","article-title":"Management of cutaneous melanoma","volume":"351","author":"Tsao","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.008_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CMR.0000000000000312","article-title":"Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland","volume":"27","author":"Minini","year":"2017","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.ejca.2022.03.008_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ijd.14334","article-title":"Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia","volume":"58","author":"Matas-Nadal","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjd.15803","article-title":"Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients","volume":"178","author":"Teramoto","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib23","first-page":"705","article-title":"From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib24","series-title":"WHO classification of skin tumours","first-page":"66","article-title":"Melanocytic tumour classification and the pathway concept of melanoma pathogenesis","author":"Elder","year":"2018"},{"key":"10.1016\/j.ejca.2022.03.008_bib25","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejca.2022.03.008_bib26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamadermatol.2018.0288","article-title":"Association of skin examination behaviors and thinner nodular vs superficial spreading melanoma at diagnosis","volume":"154","author":"Dessinioti","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jnci\/djy086","article-title":"Primary melanoma histologic subtype: impact on survival and response to therapy","volume":"111","author":"Lattanzi","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2022.03.008_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djz034","article-title":"Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers","author":"Dessinioti","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2022.03.008_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib30","series-title":"WHO classification of skin tumours","first-page":"105","article-title":"Desmoplastic melanoma","author":"Scolyer","year":"2018"},{"key":"10.1016\/j.ejca.2022.03.008_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00877248","article-title":"Phase II study of didemnin B in advanced colorectal cancer","volume":"10","author":"Jones","year":"1992","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.ejca.2022.03.008_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/CMR.0000000000000571","article-title":"Amelanotic melanoma","author":"Gong","year":"2019","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2018.04.045","article-title":"Clinically amelanotic or hypomelanotic melanoma: anatomic distribution, risk factors, and survival","volume":"79","author":"Wee","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1755-148X.2011.00880.x","article-title":"The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin","volume":"24","author":"Whiteman","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib35","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.008_bib36","series-title":"WHO classification of skin tumours","first-page":"72","article-title":"The genomic landscape of melanoma","author":"Bastian","year":"2018"},{"key":"10.1016\/j.ejca.2022.03.008_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092359","article-title":"Distinct mutation patterns reveal melanoma subtypes and influence immunotherapy response in advanced melanoma patients","volume":"12","author":"Hilke","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.03.008_bib38","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0959-8049(03)00325-3","article-title":"Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas","volume":"39","author":"Spatz","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.0303-6987.2006.00452.x","article-title":"The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma","volume":"33","author":"Scolyer","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2022.03.008_bib40","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.2011.38.8561","article-title":"Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib41","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2011.38.0584","article-title":"Superior outcome of women with stage I\/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials","volume":"30","author":"Joosse","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg (Chicago, Ill: 1960)"},{"key":"10.1016\/j.ejca.2022.03.008_bib43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.008_bib44","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1200\/JCO.19.03034","article-title":"Prognosis of patients with stage III melanoma according to American Joint committee on cancer version 8: a reassessment on the basis of 3 independent stage III melanoma cohorts","volume":"38","author":"Garbe","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archderm.141.4.434","article-title":"First prospective study of the recognition process of melanoma in dermatological practice","volume":"141","author":"Gachon","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mjd.2003.216","article-title":"Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection","volume":"48","author":"Chamberlain","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archderm.134.1.103-a","article-title":"The \u2018ugly duckling\u2019 sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening","volume":"134","author":"Grob","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1470-2045(02)00679-4","article-title":"Diagnostic accuracy of dermoscopy","volume":"3","author":"Kittler","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008390-199602000-00008","article-title":"A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma","volume":"6","author":"Menzies","year":"1996","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0190-9622(94)70061-3","article-title":"The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions","volume":"30","author":"Nachbar","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib51","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-2133.2011.10621.x","article-title":"Blue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma","volume":"165","author":"Argenziano","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mjd.2003.281","article-title":"Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet","volume":"48","author":"Argenziano","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/jamadermatol.2017.6447","article-title":"Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ","volume":"154","author":"Lallas","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib54","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archderm.142.9.1113","article-title":"Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging","volume":"142","author":"Kittler","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib55","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archderm.144.9.1120","article-title":"Dermoscopic evaluation of amelanotic and hypomelanotic melanoma","volume":"144","author":"Menzies","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2010.01140.x","article-title":"Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanoma","volume":"38","author":"Moloney","year":"2011","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib57","first-page":"91","article-title":"Dermoscopic features of difficult melanoma","volume":"33","author":"Pizzichetta","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2022.03.008_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archdermatol.2011.136","article-title":"Revised 3-step dermoscopic algorithm for the management of acral melanocytic lesions","volume":"147","author":"Koga","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000372-198911020-00003","article-title":"Malignant melanoma in situ on the sole of the foot. Its clinical and histopathologic characteristics","volume":"11","author":"Saida","year":"1989","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2022.03.008_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0738-081X(02)00219-5","article-title":"Dermoscopy for acral pigmented skin lesions","volume":"20","author":"Saida","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1346-8138.2010.01174.x","article-title":"Key points in dermoscopic differentiation between early acral melanoma and acral nevus","volume":"38","author":"Saida","year":"2011","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib62","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archderm.142.9.1123","article-title":"Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy","volume":"142","author":"Altamura","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0738-081X(02)00221-3","article-title":"Dermatoscopy for facial pigmented skin lesions","volume":"20","author":"Stolz","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0190-9622(00)90005-7","article-title":"Improvement of early recognition of lentigo maligna using dermatoscopy","volume":"42","author":"Schiffner","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib65","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2133.2012.10932.x","article-title":"Dermoscopy of lentigo maligna melanoma: report of 125 cases","volume":"167","author":"Pralong","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib66","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archderm.138.10.1327","article-title":"Dermoscopic examination of nail pigmentation","volume":"138","author":"Ronger","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib67","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archdermatol.2011.155","article-title":"Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction: results of a multicenter study by the International Dermoscopy Society (IDS)","volume":"147","author":"Blum","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib68","series-title":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): diagnostik, Therapie und Nachsorge des Melanoms, Langversion 3.1","author":"Onkologie","year":"2018"},{"issue":"Suppl 6:1\u2013116","key":"10.1016\/j.ejca.2022.03.008_bib69","first-page":"1","article-title":"Malignant melanoma S3-guideline \"diagnosis, therapy and follow-up of melanoma","volume":"11","author":"Pflugfelder","year":"2013","journal-title":"J Dtsch Dermatol Ges = J German Soc Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib70","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/archderm.144.12.1618","article-title":"The furrow ink test: a clue for the dermoscopic diagnosis of acral melanoma vs nevus","volume":"144","author":"Braun","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1346-8138.2010.01175.x","article-title":"Key point in dermoscopic differentiation between early nail apparatus melanoma and benign longitudinal melanonychia","volume":"38","author":"Koga","year":"2011","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib72","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2133.2009.09594.x","article-title":"Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population","volume":"162","author":"Phan","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib73","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.14045","article-title":"The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma","volume":"173","author":"Lallas","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib74","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archderm.138.10.1379","article-title":"Follow-up of melanocytic skin lesions with digital dermoscopy: risks and benefits","volume":"138","author":"Kittler","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2133.2005.06370.x","article-title":"Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy","volume":"152","author":"Bauer","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib76","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.jid.5700119","article-title":"Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma","volume":"126","author":"Haenssle","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib77","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.jaad.2011.04.008","article-title":"Benefits of total body photography and digital dermatoscopy (\"two-step method of digital follow-up\") in the early diagnosis of melanoma in patients at high risk for melanoma","volume":"67","author":"Salerni","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ejca.2022.03.008_bib78","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaad.2019.08.074","article-title":"Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring","volume":"82","author":"Lallas","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib79","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaad.2012.01.028","article-title":"Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma","volume":"67","author":"Salerni","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0190-9622(03)02794-4","article-title":"Detection of melanomas in patients followed up with total cutaneous examinations, total cutaneous photography, and dermoscopy","volume":"50","author":"Wang","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib81","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0190-9622(98)70086-6","article-title":"Intervention strategy to prevent lethal cutaneous\u00a0melanoma: use of dermatologic photography to aid surveillance of high-risk persons","volume":"39","author":"Rhodes","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib82","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archderm.144.4.502","article-title":"Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma","volume":"144","author":"Altamura","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib83","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1071\/HC10268","article-title":"Digital monitoring by whole body photography and sequential digital dermoscopy detects thinner melanomas","volume":"2","author":"Rademaker","year":"2010","journal-title":"J Prim Health Care"},{"key":"10.1016\/j.ejca.2022.03.008_bib84","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1365-2133.2009.09374.x","article-title":"Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial","volume":"161","author":"Menzies","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109339","article-title":"Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi","volume":"9","author":"Tromme","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2022.03.008_bib86","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/bjd.13148","article-title":"Reflectance confocal microscopy as a second-level examination in skin oncology improves diagnostic accuracy and saves unnecessary excisions: a longitudinal prospective study","volume":"171","author":"Pellacani","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib87","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamadermatol.2016.1188","article-title":"Clinical indications for use of reflectance confocal microscopy for skin cancer diagnosis","volume":"152","author":"Borsari","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib88","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/bjd.12678","article-title":"Impact of in\u00a0vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions","volume":"170","author":"Alarcon","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib89","first-page":"Cd013190","article-title":"Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2022.03.008_bib90","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamadermatol.2017.3114","article-title":"Correlation of handheld reflectance confocal microscopy with radial video mosaicing for margin mapping of lentigo maligna and lentigo maligna melanoma","volume":"153","author":"Yelamos","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib91","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/bjd.13121","article-title":"Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety","volume":"171","author":"Malvehy","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib92","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejca.2021.06.049","article-title":"Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts","volume":"156","author":"Haggenm\u00fcller","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib93","first-page":"Cd013186","article-title":"Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults","volume":"12","author":"Ferrante di Ruffano","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2022.03.008_bib94","doi-asserted-by":"crossref","first-page":"m127","DOI":"10.1136\/bmj.m127","article-title":"Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies","volume":"368","author":"Freeman","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2022.03.008_bib95","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/sonc.2002.34116","article-title":"Pathologic staging of melanoma","volume":"29","author":"Ruiter","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib96","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2017.05.015","article-title":"Discrepancy in BRAF status among patients with metastatic malignant melanoma: a meta-analysis","volume":"81","author":"Valachis","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fmolb.2020.00113","article-title":"The current state of molecular testing in the BRAF-mutated melanoma landscape","volume":"7","author":"Vanni","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ejca.2022.03.008_bib98","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1470-2045(17)30180-8","article-title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Dummer","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2018.04.010","article-title":"MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: results of a retrospective multicentre analysis of 364 patients","volume":"98","author":"Kirchberger","year":"2018","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2022.03.008_bib100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-018-0414-1","article-title":"KIT as an oncogenic driver in melanoma: an update on clinical development","volume":"20","author":"Meng","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib101","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2022.03.008_bib102","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.pathol.2018.08.004","article-title":"Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases","volume":"50","author":"Leichsenring","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.ejca.2022.03.008_bib103","doi-asserted-by":"crossref","first-page":"706652","DOI":"10.3389\/fonc.2021.706652","article-title":"Prognostic role of tumor mutational burden in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib104","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib105","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA approval summary: pembrolizumab for the treatment of tumor mutational burden-high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s40425-019-0659-0","article-title":"Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study","volume":"7","author":"Forschner","year":"2019","journal-title":"J Immuno Ther Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib107","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.annonc.2021.09.016","article-title":"Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project","volume":"32","author":"Vega","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib108","first-page":"100447","article-title":"Gene expression profiling in melanoma: a view from the clinic","volume":"29","author":"Bollard","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ejca.2022.03.008_bib109","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jamadermatol.2020.1729","article-title":"Prognostic gene expression profiling in cutaneous melanoma: identifying the knowledge gaps and assessing the clinical benefit","volume":"156","author":"Grossman","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189714","article-title":"Liquid biopsy in melanoma: significance in diagnostics, prediction and treatment monitoring","volume":"22","author":"Kami\u0144ska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2022.03.008_bib111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/jdv.15194","article-title":"Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry","volume":"33","author":"Gassenmaier","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2022.03.008_bib112","article-title":"Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma","volume":"7","author":"Dinnes","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2022.03.008_bib113","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1309\/AJCPWSDDHLLW40WI","article-title":"Fine-needle aspiration cytology for the diagnosis of metastatic melanoma: systematic review and meta-analysis","volume":"140","author":"Hall","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejca.2022.03.008_bib114","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ejso.2017.02.009","article-title":"Long-term results of ultrasound guided fine needle aspiration cytology in conjunction with sentinel node biopsy support step-wise approach in melanoma","volume":"43","author":"Oude Ophuis","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/CMR.0000000000000161","article-title":"Ultrasound-guided core needle biopsy of superficial lymph nodes: an alternative to fine-needle aspiration cytology for the diagnosis of lymph node metastasis in cutaneous melanoma","volume":"25","author":"Bohelay","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib116","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib117","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.008_bib118","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint committee on cancer (AJCC) 8th edition and beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib119","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1200\/JCO.2006.05.6176","article-title":"Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF02306618","article-title":"Computed tomography in evaluation of patients with stage III melanoma","volume":"4","author":"Kuvshinoff","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib121","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF02305552","article-title":"Computed tomography in staging of patients with melanoma metastatic to the regional nodes","volume":"4","author":"Johnson","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib122","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/2046-4053-1-62","article-title":"F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET\/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review","volume":"1","author":"Schroer-Gunther","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejca.2022.03.008_bib123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","article-title":"Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study","volume":"27","author":"Stensheim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib124","first-page":"11","article-title":"Pregnancy history and incidence of melanoma in women: a pooled analysis","volume":"17","author":"Karagas","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2022.03.008_bib125","first-page":"437","article-title":"Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues","volume":"19","author":"Lens","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2022.03.008_bib126","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.20925","article-title":"Malignant melanoma in pregnancy. A population-based evaluation","volume":"103","author":"O'Meara","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib127","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.2004.02.096","article-title":"Effect of pregnancy on survival in women with cutaneous malignant melanoma","volume":"22","author":"Lens","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1753495X17695001","article-title":"Melanoma in pregnancy","volume":"10","author":"Still","year":"2017","journal-title":"Obstet Med"},{"issue":"11","key":"10.1016\/j.ejca.2022.03.008_bib129","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1158\/1055-9965.EPI-19-0554","article-title":"Menopausal hormone therapy and risk of melanoma: a nationwide register-based study in Finland","volume":"28","author":"Botteri","year":"2019","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejca.2022.03.008_bib130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib131","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/CMR.0000000000000395","article-title":"Multiple primary melanoma: a single centre retrospective review","volume":"27","author":"Menzies","year":"2017","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.03.008_bib132","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/annonc\/mdx040","article-title":"Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study","volume":"28","author":"Dreno","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib133","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2014.55.0590","article-title":"Safety and management of new primary melanomas during receipt of BRAF inhibitors","volume":"32","author":"Perier-Muzet","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib134","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2015.10.029","article-title":"Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single-institution cohort","volume":"74","author":"Hwang","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib135","first-page":"18","article-title":"A global review of melanoma follow-up guidelines","volume":"6","author":"Trotter","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib136","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.294.13.1647","article-title":"Clinicopathological features of and risk factors for multiple primary melanomas","volume":"294","author":"Ferrone","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2022.03.008_bib137","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jaad.2015.06.059","article-title":"Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011","volume":"73","author":"Moore","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2022.03.008_bib138","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jamadermatol.2021.4704","article-title":"Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial","volume":"158","author":"Ackermann","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib139","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.008_bib140","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1158\/1055-9965.EPI-12-1346","article-title":"Dysplastic nevi and melanoma","volume":"22","author":"Goldstein","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejca.2022.03.008_bib141","first-page":"204","article-title":"Serum levels of S-100b protein after four years follow-up of patients with melanoma","volume":"9","author":"Zissimopoulos","year":"2006","journal-title":"Hellenic J Nucl Med"},{"key":"10.1016\/j.ejca.2022.03.008_bib142","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejso.2011.12.005","article-title":"The current status of S-100B as a biomarker in melanoma","volume":"38","author":"Kruijff","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib143","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1245\/s10434-010-1085-1","article-title":"Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival","volume":"17","author":"Kruijff","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.008_bib144","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis","volume":"103","author":"Xing","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2022.03.008_bib145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.clindermatol.2009.06.013","article-title":"Incisional biopsy and melanoma prognosis: facts and controversies","volume":"28","author":"Pflugfelder","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib146","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejca.2017.07.051","article-title":"Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: a comparative cohort study","volume":"85","author":"Ribero","year":"2017","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2022.03.008_bib147","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jaad.2019.05.076","article-title":"Diagnostic accuracy of imaging studies for initial staging of T2b-T4b melanoma patients. A cross-sectional study","volume":"81","author":"Riquelme-Mc Loughlin","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib148","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaad.2016.02.1229","article-title":"Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: a prospective cohort study","volume":"75","author":"Podlipnik","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.008_bib149","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/bjd.16833","article-title":"Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma","volume":"180","author":"Podlipnik","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:38:06Z","timestamp":1760733486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":149,"alternative-id":["S0959804922001526"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.03.008","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.04.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}